ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PK/PD Modeling Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-11G17644
Home | Market Reports | Computers & Electronics| Software
Global PK PD Modeling Market Research Report 2024
BUY CHAPTERS

Global PK/PD Modeling Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11G17644
Report
October 2025
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Certara
Labcorp Drug Development
Comac Medical
Seda S.p.A
Quanticate
BioPharma Services Inc.
Kaituo Pharmaceutical
Allucent
NorthEast Biolab
Pipeline Biotech
PhInc. Modeling
Lilly Careers

PK/PD Modeling Market

The global PK/PD Modeling market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
PK/PD modeling (pharmacokinetic/pharmacodynamic modeling) plays an important role in drug research and development. It can integrate pharmacokinetic (PK) and pharmacodynamic (PD) data to build a reasonable mathematical model, Helps analyze the behavior of drugs in the body and their effects on the body.
From a downstream perspective, Drug Discovery accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
PK/PD Modeling leading manufacturers including Certara, Labcorp Drug Development, Comac Medical, Seda, Quanticate, Pipeline Biotech, PhInc. Modeling, Lilly Careers, BioPharma Services Inc., Kaituo Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Certara leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global PK/PD Modeling market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of PK/PD Modeling Market Report

Report Metric Details
Report Name PK/PD Modeling Market
Segment by Type
  • Direct Connection to PK/PD Model
  • Indirect Connection PK/PD Model
Segment by Application
  • Drug Discovery
  • Clinical Trials
  • Market Assessment
  • Traditional Chinese Medicine Research
  • Clinical Medication Guidance
  • Model Pptimization and Technological Innovation
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Certara, Labcorp Drug Development, Comac Medical, Seda, Quanticate, Pipeline Biotech, PhInc. Modeling, Lilly Careers, BioPharma Services Inc., Kaituo Pharmaceutical, Allucent, NorthEast BioLab
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the PK/PD Modeling study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the PK/PD Modeling Market report?

Ans: The main players in the PK/PD Modeling Market are Certara, Labcorp Drug Development, Comac Medical, Seda, Quanticate, Pipeline Biotech, PhInc. Modeling, Lilly Careers, BioPharma Services Inc., Kaituo Pharmaceutical, Allucent, NorthEast BioLab

What are the Application segmentation covered in the PK/PD Modeling Market report?

Ans: The Applications covered in the PK/PD Modeling Market report are Drug Discovery, Clinical Trials, Market Assessment, Traditional Chinese Medicine Research, Clinical Medication Guidance, Model Pptimization and Technological Innovation, Others

What are the Type segmentation covered in the PK/PD Modeling Market report?

Ans: The Types covered in the PK/PD Modeling Market report are Direct Connection to PK/PD Model, Indirect Connection PK/PD Model

Recommended Reports

PK/PD & ADME Markets

Disease Drug Markets

Diagnostics & Therapy

1 Study Coverage
1.1 Introduction to PK/PD Modeling: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global PK/PD Modeling Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Direct Connection to PK/PD Model
1.2.3 Indirect Connection PK/PD Model
1.3 Market Segmentation by Application
1.3.1 Global PK/PD Modeling Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Clinical Trials
1.3.4 Market Assessment
1.3.5 Traditional Chinese Medicine Research
1.3.6 Clinical Medication Guidance
1.3.7 Model Pptimization and Technological Innovation
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global PK/PD Modeling Revenue Estimates and Forecasts 2020-2031
2.2 Global PK/PD Modeling Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global PK/PD Modeling Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global PK/PD Modeling Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Direct Connection to PK/PD Model Market Size by Players
3.3.2 Indirect Connection PK/PD Model Market Size by Players
3.4 Global PK/PD Modeling Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global PK/PD Modeling Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global PK/PD Modeling Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America PK/PD Modeling Market Size by Type (2020-2031)
6.4 North America PK/PD Modeling Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America PK/PD Modeling Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe PK/PD Modeling Market Size by Type (2020-2031)
7.4 Europe PK/PD Modeling Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe PK/PD Modeling Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific PK/PD Modeling Market Size by Type (2020-2031)
8.4 Asia-Pacific PK/PD Modeling Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific PK/PD Modeling Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America PK/PD Modeling Market Size by Type (2020-2031)
9.4 Central and South America PK/PD Modeling Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America PK/PD Modeling Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa PK/PD Modeling Market Size by Type (2020-2031)
10.4 Middle East and Africa PK/PD Modeling Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa PK/PD Modeling Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Certara
11.1.1 Certara Corporation Information
11.1.2 Certara Business Overview
11.1.3 Certara PK/PD Modeling Product Features and Attributes
11.1.4 Certara PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.1.5 Certara PK/PD Modeling Revenue by Product in 2024
11.1.6 Certara PK/PD Modeling Revenue by Application in 2024
11.1.7 Certara PK/PD Modeling Revenue by Geographic Area in 2024
11.1.8 Certara PK/PD Modeling SWOT Analysis
11.1.9 Certara Recent Developments
11.2 Labcorp Drug Development
11.2.1 Labcorp Drug Development Corporation Information
11.2.2 Labcorp Drug Development Business Overview
11.2.3 Labcorp Drug Development PK/PD Modeling Product Features and Attributes
11.2.4 Labcorp Drug Development PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.2.5 Labcorp Drug Development PK/PD Modeling Revenue by Product in 2024
11.2.6 Labcorp Drug Development PK/PD Modeling Revenue by Application in 2024
11.2.7 Labcorp Drug Development PK/PD Modeling Revenue by Geographic Area in 2024
11.2.8 Labcorp Drug Development PK/PD Modeling SWOT Analysis
11.2.9 Labcorp Drug Development Recent Developments
11.3 Comac Medical
11.3.1 Comac Medical Corporation Information
11.3.2 Comac Medical Business Overview
11.3.3 Comac Medical PK/PD Modeling Product Features and Attributes
11.3.4 Comac Medical PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.3.5 Comac Medical PK/PD Modeling Revenue by Product in 2024
11.3.6 Comac Medical PK/PD Modeling Revenue by Application in 2024
11.3.7 Comac Medical PK/PD Modeling Revenue by Geographic Area in 2024
11.3.8 Comac Medical PK/PD Modeling SWOT Analysis
11.3.9 Comac Medical Recent Developments
11.4 Seda
11.4.1 Seda Corporation Information
11.4.2 Seda Business Overview
11.4.3 Seda PK/PD Modeling Product Features and Attributes
11.4.4 Seda PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.4.5 Seda PK/PD Modeling Revenue by Product in 2024
11.4.6 Seda PK/PD Modeling Revenue by Application in 2024
11.4.7 Seda PK/PD Modeling Revenue by Geographic Area in 2024
11.4.8 Seda PK/PD Modeling SWOT Analysis
11.4.9 Seda Recent Developments
11.5 Quanticate
11.5.1 Quanticate Corporation Information
11.5.2 Quanticate Business Overview
11.5.3 Quanticate PK/PD Modeling Product Features and Attributes
11.5.4 Quanticate PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.5.5 Quanticate PK/PD Modeling Revenue by Product in 2024
11.5.6 Quanticate PK/PD Modeling Revenue by Application in 2024
11.5.7 Quanticate PK/PD Modeling Revenue by Geographic Area in 2024
11.5.8 Quanticate PK/PD Modeling SWOT Analysis
11.5.9 Quanticate Recent Developments
11.6 Pipeline Biotech
11.6.1 Pipeline Biotech Corporation Information
11.6.2 Pipeline Biotech Business Overview
11.6.3 Pipeline Biotech PK/PD Modeling Product Features and Attributes
11.6.4 Pipeline Biotech PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.6.5 Pipeline Biotech Recent Developments
11.7 PhInc. Modeling
11.7.1 PhInc. Modeling Corporation Information
11.7.2 PhInc. Modeling Business Overview
11.7.3 PhInc. Modeling PK/PD Modeling Product Features and Attributes
11.7.4 PhInc. Modeling PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.7.5 PhInc. Modeling Recent Developments
11.8 Lilly Careers
11.8.1 Lilly Careers Corporation Information
11.8.2 Lilly Careers Business Overview
11.8.3 Lilly Careers PK/PD Modeling Product Features and Attributes
11.8.4 Lilly Careers PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.8.5 Lilly Careers Recent Developments
11.9 BioPharma Services Inc.
11.9.1 BioPharma Services Inc. Corporation Information
11.9.2 BioPharma Services Inc. Business Overview
11.9.3 BioPharma Services Inc. PK/PD Modeling Product Features and Attributes
11.9.4 BioPharma Services Inc. PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.9.5 BioPharma Services Inc. Recent Developments
11.10 Kaituo Pharmaceutical
11.10.1 Kaituo Pharmaceutical Corporation Information
11.10.2 Kaituo Pharmaceutical Business Overview
11.10.3 Kaituo Pharmaceutical PK/PD Modeling Product Features and Attributes
11.10.4 Kaituo Pharmaceutical PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Allucent
11.11.1 Allucent Corporation Information
11.11.2 Allucent Business Overview
11.11.3 Allucent PK/PD Modeling Product Features and Attributes
11.11.4 Allucent PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.11.5 Allucent Recent Developments
11.12 NorthEast BioLab
11.12.1 NorthEast BioLab Corporation Information
11.12.2 NorthEast BioLab Business Overview
11.12.3 NorthEast BioLab PK/PD Modeling Product Features and Attributes
11.12.4 NorthEast BioLab PK/PD Modeling Revenue and Gross Margin (2020-2025)
11.12.5 NorthEast BioLab Recent Developments
12 PK/PD ModelingIndustry Chain Analysis
12.1 PK/PD Modeling Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 PK/PD Modeling Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global PK/PD Modeling Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Certara
Labcorp Drug Development
Comac Medical
Seda S.p.A
Quanticate
BioPharma Services Inc.
Kaituo Pharmaceutical
Allucent
NorthEast Biolab
Pipeline Biotech
PhInc. Modeling
Lilly Careers
List of Tables
 Table 1. Global PK/PD Modeling Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global PK/PD Modeling Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global PK/PD Modeling Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global PK/PD Modeling Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global PK/PD Modeling Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global PK/PD Modeling Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global PK/PD Modeling Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global PK/PD Modeling by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PK/PD Modeling as of 2024)
 Table 11. Global PK/PD Modeling Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global PK/PD Modeling Companies Headquarters
 Table 13. Global PK/PD Modeling Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global PK/PD Modeling Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global PK/PD Modeling Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global PK/PD Modeling Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global PK/PD Modeling Revenue by Application (2026-2031) & (US$ Million)
 Table 21. PK/PD Modeling High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America PK/PD Modeling Growth Accelerators and Market Barriers
 Table 25. North America PK/PD Modeling Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe PK/PD Modeling Growth Accelerators and Market Barriers
 Table 27. Europe PK/PD Modeling Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific PK/PD Modeling Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific PK/PD Modeling Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America PK/PD Modeling Investment Opportunities and Key Challenges
 Table 31. Central and South America PK/PD Modeling Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa PK/PD Modeling Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa PK/PD Modeling Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Certara Corporation Information
 Table 35. Certara Description and Major Businesses
 Table 36. Certara Product Features and Attributes
 Table 37. Certara Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Certara Revenue Proportion by Product in 2024
 Table 39. Certara Revenue Proportion by Application in 2024
 Table 40. Certara Revenue Proportion by Geographic Area in 2024
 Table 41. Certara PK/PD Modeling SWOT Analysis
 Table 42. Certara Recent Developments
 Table 43. Labcorp Drug Development Corporation Information
 Table 44. Labcorp Drug Development Description and Major Businesses
 Table 45. Labcorp Drug Development Product Features and Attributes
 Table 46. Labcorp Drug Development Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Labcorp Drug Development Revenue Proportion by Product in 2024
 Table 48. Labcorp Drug Development Revenue Proportion by Application in 2024
 Table 49. Labcorp Drug Development Revenue Proportion by Geographic Area in 2024
 Table 50. Labcorp Drug Development PK/PD Modeling SWOT Analysis
 Table 51. Labcorp Drug Development Recent Developments
 Table 52. Comac Medical Corporation Information
 Table 53. Comac Medical Description and Major Businesses
 Table 54. Comac Medical Product Features and Attributes
 Table 55. Comac Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Comac Medical Revenue Proportion by Product in 2024
 Table 57. Comac Medical Revenue Proportion by Application in 2024
 Table 58. Comac Medical Revenue Proportion by Geographic Area in 2024
 Table 59. Comac Medical PK/PD Modeling SWOT Analysis
 Table 60. Comac Medical Recent Developments
 Table 61. Seda Corporation Information
 Table 62. Seda Description and Major Businesses
 Table 63. Seda Product Features and Attributes
 Table 64. Seda Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Seda Revenue Proportion by Product in 2024
 Table 66. Seda Revenue Proportion by Application in 2024
 Table 67. Seda Revenue Proportion by Geographic Area in 2024
 Table 68. Seda PK/PD Modeling SWOT Analysis
 Table 69. Seda Recent Developments
 Table 70. Quanticate Corporation Information
 Table 71. Quanticate Description and Major Businesses
 Table 72. Quanticate Product Features and Attributes
 Table 73. Quanticate Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Quanticate Revenue Proportion by Product in 2024
 Table 75. Quanticate Revenue Proportion by Application in 2024
 Table 76. Quanticate Revenue Proportion by Geographic Area in 2024
 Table 77. Quanticate PK/PD Modeling SWOT Analysis
 Table 78. Quanticate Recent Developments
 Table 79. Pipeline Biotech Corporation Information
 Table 80. Pipeline Biotech Description and Major Businesses
 Table 81. Pipeline Biotech Product Features and Attributes
 Table 82. Pipeline Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Pipeline Biotech Recent Developments
 Table 84. PhInc. Modeling Corporation Information
 Table 85. PhInc. Modeling Description and Major Businesses
 Table 86. PhInc. Modeling Product Features and Attributes
 Table 87. PhInc. Modeling Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. PhInc. Modeling Recent Developments
 Table 89. Lilly Careers Corporation Information
 Table 90. Lilly Careers Description and Major Businesses
 Table 91. Lilly Careers Product Features and Attributes
 Table 92. Lilly Careers Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Lilly Careers Recent Developments
 Table 94. BioPharma Services Inc. Corporation Information
 Table 95. BioPharma Services Inc. Description and Major Businesses
 Table 96. BioPharma Services Inc. Product Features and Attributes
 Table 97. BioPharma Services Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. BioPharma Services Inc. Recent Developments
 Table 99. Kaituo Pharmaceutical Corporation Information
 Table 100. Kaituo Pharmaceutical Description and Major Businesses
 Table 101. Kaituo Pharmaceutical Product Features and Attributes
 Table 102. Kaituo Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Kaituo Pharmaceutical Recent Developments
 Table 104. Allucent Corporation Information
 Table 105. Allucent Description and Major Businesses
 Table 106. Allucent Product Features and Attributes
 Table 107. Allucent Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Allucent Recent Developments
 Table 109. NorthEast BioLab Corporation Information
 Table 110. NorthEast BioLab Description and Major Businesses
 Table 111. NorthEast BioLab Product Features and Attributes
 Table 112. NorthEast BioLab Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. NorthEast BioLab Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. PK/PD Modeling Product Picture
 Figure 2. Global PK/PD Modeling Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Direct Connection to PK/PD Model Product Picture
 Figure 4. Indirect Connection PK/PD Model Product Picture
 Figure 5. Global PK/PD Modeling Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Drug Discovery
 Figure 7. Clinical Trials
 Figure 8. Market Assessment
 Figure 9. Traditional Chinese Medicine Research
 Figure 10. Clinical Medication Guidance
 Figure 11. Model Pptimization and Technological Innovation
 Figure 12. Others
 Figure 13. PK/PD Modeling Report Years Considered
 Figure 14. Global PK/PD Modeling Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 16. Global PK/PD Modeling Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global PK/PD Modeling Revenue Market Share by Region (2020-2031)
 Figure 18. Global PK/PD Modeling Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Direct Connection to PK/PD Model Revenue Market Share by Player in 2024
 Figure 21. Indirect Connection PK/PD Model Revenue Market Share by Player in 2024
 Figure 22. Global PK/PD Modeling Revenue Market Share by Type (2020-2031)
 Figure 23. Global PK/PD Modeling Revenue Market Share by Application (2020-2031)
 Figure 24. North America PK/PD Modeling Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. North America Top 5 Players PK/PD Modeling Revenue (US$ Million) in 2024
 Figure 26. North America PK/PD Modeling Revenue (US$ Million) by Type (2020 - 2031)
 Figure 27. North America PK/PD Modeling Revenue (US$ Million) by Application (2020-2031)
 Figure 28. US PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 29. Canada PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 30. Mexico PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 31. Europe PK/PD Modeling Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Europe Top 5 Players PK/PD Modeling Revenue (US$ Million) in 2024
 Figure 33. Europe PK/PD Modeling Revenue (US$ Million) by Type (2020-2031)
 Figure 34. Europe PK/PD Modeling Revenue (US$ Million) by Application (2020-2031)
 Figure 35. Germany PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 36. France PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 37. U.K. PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 38. Italy PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 39. Russia PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific PK/PD Modeling Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Top 8 Players PK/PD Modeling Revenue (US$ Million) in 2024
 Figure 42. Asia-Pacific PK/PD Modeling Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Asia-Pacific PK/PD Modeling Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Indonesia PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 45. Japan PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 46. South Korea PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 47. Australia PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 48. India PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 49. Indonesia PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 50. Vietnam PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 51. Malaysia PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 52. Philippines PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 53. Singapore PK/PD Modeling Revenue (2020-2031) & (US$ Million)
 Figure 54. Central and South America PK/PD Modeling Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Central and South America Top 5 Players PK/PD Modeling Revenue (US$ Million) in 2024
 Figure 56. Central and South America PK/PD Modeling Revenue (US$ Million) by Type (2020-2031)
 Figure 57. Central and South America PK/PD Modeling Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Brazil PK/PD Modeling Revenue (2020-2025) & (US$ Million)
 Figure 59. Argentina PK/PD Modeling Revenue (2020-2025) & (US$ Million)
 Figure 60. Middle East and Africa PK/PD Modeling Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Middle East and Africa Top 5 Players PK/PD Modeling Revenue (US$ Million) in 2024
 Figure 62. South America PK/PD Modeling Revenue (US$ Million) by Type (2020-2031)
 Figure 63. Middle East and Africa PK/PD Modeling Revenue (US$ Million) by Application (2020-2031)
 Figure 64. GCC Countries PK/PD Modeling Revenue (2020-2025) & (US$ Million)
 Figure 65. Israel PK/PD Modeling Revenue (2020-2025) & (US$ Million)
 Figure 66. Egypt PK/PD Modeling Revenue (2020-2025) & (US$ Million)
 Figure 67. South Africa PK/PD Modeling Revenue (2020-2025) & (US$ Million)
 Figure 68. PK/PD Modeling Industry Chain Mapping
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Drug Metabolism and Pharmacokinetics DMPK Service Market Research Report 2024
Global Preclinical DMPK Studies Market Research Report 2024
Global ADME DMPK Studies Market Research Report 2024
Global Pharmacokinetic Service Market Research Report 2025
Global Pharmacokinetic Research Market Research Report 2024
Drug Modeling Softwares Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacodynamic PD Biomarkers Market Research Report 2025
Global In Vivo Pharmacology Model Market Research Report 2024
Global Pharmacokinetics Software Market Research Report 2024
Global Pharmacokinetic Research Service Market Research Report 2024
Global Quantitative Structure Activity Relationship QSAR Market Research Report 2024
Global Pharmacokinetics Testing Service Market Research Report 2024
In Vivo and In Vitro ADME and PK Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacology Discovery Service Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Market Research Report 2024
Global DMPK Service Market Research Report 2024
Pharmacokinetic Evaluation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacokinetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacodynamic Biomarker Assay Market Research Report 2024
Pharmacodynamic Biomarker Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global In-service Inspection Services for Nuclear Facilities Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33X20008
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Marketing Work Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32Z20025
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Marketing Dashboard Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33J20012
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Industrial CT Inspection Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Q20225
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions